A BIOCHEMICAL ABNORMALITY IN HEREDIATRY ANGIONEUROTIC EDEMA: ABSENCE OF SERUM INHIBITOR OF C' 1-ESTERASE.
about
Studies in vivo and in vitro on an abnormality in the metabolism of C3 in a patient with increased susceptibility to infectionIdentification of a new P1 residue mutation (444Arg----Ser) in a dysfunctional C1 inhibitor protein contained in a type II hereditary angioedema plasmaDysfunctional C1 inhibitor Ta: deletion of Lys-251 results in acquisition of an N-glycosylation siteClusters of intragenic Alu repeats predispose the human C1 inhibitor locus to deleterious rearrangementsType II hereditary angioneurotic edema that may result from a single nucleotide change in the codon for alanine-436 in the C1 inhibitor geneNonsense mutations affect C1 inhibitor messenger RNA levels in patients with type I hereditary angioneurotic edemaDiagnosis and screening of patients with hereditary angioedema in primary careHuman genetic basis of interindividual variability in the course of infectionRecombinant replacement therapy for hereditary angioedema due to C1 inhibitor deficiencyHereditary and acquired complement component 1 esterase inhibitor deficiency: a review for the hematologistAngioedema: Classification, management and emerging therapies for the perioperative physicianAngio-oedema in relation to treatment with angiotensin converting enzyme inhibitorsThe inhibition of plasmin, plasma kallikrein, plasma permeability factor, and the C'1r subcomponent of the first component of complement by serum C'1 esterase inhibitorHereditary Angioedema Caused By C1-Esterase Inhibitor Deficiency: A Literature-Based Analysis and Clinical Commentary on Prophylaxis Treatment StrategiesSimultaneous estimation of bidirectional particle flow and relative flux using MUSIC-OCT: phantom studies.Management of hereditary angioedema in 2012: scientific and pharmacoeconomic perspectives.Proteinase inhibitors in rheumatoid arthritis.Increased incidence of angioedema with ACE inhibitors in combination with mTOR inhibitors in kidney transplant recipientsIndividuality in disease and therapy.HAE therapies: past present and future.2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema.Genetically determined heterogeneity of the C1 esterase inhibitor in patients with hereditary angioneurotic edema.Complete nucleotide sequence of the gene for human C1 inhibitor with an unusually high density of Alu elements.Plasma levels of C1- inhibitor complexes and cleaved C1- inhibitor in patients with hereditary angioneurotic edema.Effect of C'1 esterase on vascular permeability in man: studies in normal and complement-deficient individuals and in patients with hereditary angioneurotic edemaFuture prospects for use of fibrinolysis inhibitorsPharmacokinetics of plasma-derived C1-esterase inhibitor after subcutaneous versus intravenous administration in subjects with mild or moderate hereditary angioedema: the PASSION study.Presence of C1-inhibitor polymers in a subset of patients suffering from hereditary angioedemaStudies on human plasma C1 inactivator-enzyme interactions. II. Structural features of an abnormal C1 inactivator from a kindred with hereditary angioneurotic edemaDemonstration of modified inactive first component of complement (C1) inhibitor in the plasmas of C1 inhibitor-deficient patientsA common neoepitope is created when the reactive center of C1-inhibitor is cleaved by plasma kallikrein, activated factor XII fragment, C1 esterase, or neutrophil elastase.Inherited incomplete deficiency of the fourth component of complement (C4) determined by a gene not linked to human histocompatibility leukocyte antigens.Clinical management of hereditary angio-oedema in children.Pediatric hereditary angioedemaEosinophilic granuloma of the gastro-intestinal tract.Hereditary angioneurotic oedema: an unusual cause of recurring abdominal pain.Laparoscopic splenectomy in a patient with acquired angioneurotic edema.Ecallantide for the treatment of hereditary angiodema in adults.Ecallantide is a novel treatment for attacks of hereditary angioedema due to C1 inhibitor deficiencyComplement and coagulation.
P2860
Q24300424-3277C963-AAAB-46E1-BCA1-D7185D3DCC51Q24339566-69FBD8E7-6EAF-4499-9E0D-F7A069EDCAF1Q24557433-9BC2974D-1592-4487-8824-F1B0A4BD7462Q24558897-2627613F-79FA-45E1-BB9E-1F07EF29E885Q24559923-50701E83-29A8-4154-A5C2-E3AD2419B613Q24632004-8BFDFCAA-4C85-4FE5-B231-0744EB003FC0Q26748520-66C23B6F-6FB6-4077-8EAF-BE3E946943CFQ26775894-A1B2A2EB-136F-4853-9DFB-CF19D5951C81Q26801368-0BF63422-902A-4026-8A18-2D650F73523AQ26823309-654775B0-A348-4B91-819E-0D5F76E4A6C4Q28076493-C7527607-EF34-4656-8F9D-93A2A04DB0AFQ28319778-7B41B729-F07D-4AFC-95C0-9DEBA78ED02DQ28630878-D6794CD0-4A68-4C43-911B-B6EA1310D9CCQ28972400-2499FA16-DB88-4DB6-BDCD-F2CD61E127DCQ30367926-966FB3D1-04B2-4CAC-81CF-DE84C5928763Q30414957-FE0849F8-C003-42D4-824E-8976385101E3Q33569368-4164867B-0234-4FD3-8B2F-91B5F8C79E89Q33769969-3518CC01-EED1-4712-BE4F-6BB1050148C0Q34022128-AB443CB8-DAFB-47DC-9B44-6286C4561D86Q34063768-793F9D80-F962-4E94-BA67-C0BC013C2DA0Q34064761-A36BD8B6-FC40-4A1B-8F9E-3B074BE60940Q34065166-856BFD25-5EFA-43F9-92E5-53C42AEC137DQ34104715-3C1A7C24-D2B9-4E92-AF65-A4AF1C93BFDCQ34248456-0CF0FB9B-A750-4809-ADCE-A0F30DACCBB4Q34272964-000E3848-E063-4204-A77D-633AA310B560Q34302626-75F64BF2-329D-4E90-8491-6EE201BB6604Q34432907-83DD6FAD-0079-449B-B65A-7585BF183609Q34450903-9C40A4ED-1CFA-4E98-A39B-E4FF4848EFE6Q34475517-0513CFB3-B719-4DF2-B2EA-7E3EA1593745Q34534792-AEB5C528-CE2A-4854-A3D6-EC05D951CD60Q34560623-0C11BC9C-F137-4632-87F7-27E734A6EBFCQ34618262-33021786-CFF2-44D5-89AD-1CACA28E540DQ34764718-ACCF08F2-63BE-4895-AA10-501C2ACD07FBQ34805433-16DD74F9-6EA2-4BE1-B853-68BB4272D889Q35002894-EDCDDBEE-FE8F-412C-9F87-E55A42A2DA6CQ35004883-F871D520-038B-475F-BAC6-17C5DFBFFF0CQ35039754-2004CEAE-7CA1-45D4-8357-ECCA6F81049BQ35046998-DF8AB723-9D7E-4AEE-8789-E0C198344987Q35096965-1F2B22E6-0EA6-46F5-B1AA-DAEC5CC8DA07Q35133187-F6BBDCBE-83E7-41A6-BB32-948406A4C3CB
P2860
A BIOCHEMICAL ABNORMALITY IN HEREDIATRY ANGIONEUROTIC EDEMA: ABSENCE OF SERUM INHIBITOR OF C' 1-ESTERASE.
description
1963 nî lūn-bûn
@nan
1963 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1963 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1963年の論文
@ja
1963年論文
@yue
1963年論文
@zh-hant
1963年論文
@zh-hk
1963年論文
@zh-mo
1963年論文
@zh-tw
1963年论文
@wuu
name
A BIOCHEMICAL ABNORMALITY IN H ...... UM INHIBITOR OF C' 1-ESTERASE.
@ast
A BIOCHEMICAL ABNORMALITY IN H ...... UM INHIBITOR OF C' 1-ESTERASE.
@en
A BIOCHEMICAL ABNORMALITY IN H ...... UM INHIBITOR OF C' 1-ESTERASE.
@nl
type
label
A BIOCHEMICAL ABNORMALITY IN H ...... UM INHIBITOR OF C' 1-ESTERASE.
@ast
A BIOCHEMICAL ABNORMALITY IN H ...... UM INHIBITOR OF C' 1-ESTERASE.
@en
A BIOCHEMICAL ABNORMALITY IN H ...... UM INHIBITOR OF C' 1-ESTERASE.
@nl
prefLabel
A BIOCHEMICAL ABNORMALITY IN H ...... UM INHIBITOR OF C' 1-ESTERASE.
@ast
A BIOCHEMICAL ABNORMALITY IN H ...... UM INHIBITOR OF C' 1-ESTERASE.
@en
A BIOCHEMICAL ABNORMALITY IN H ...... UM INHIBITOR OF C' 1-ESTERASE.
@nl
P1476
A BIOCHEMICAL ABNORMALITY IN H ...... UM INHIBITOR OF C' 1-ESTERASE.
@en
P2093
DONALDSON VH
P356
10.1016/0002-9343(63)90162-1
P407
P577
1963-07-01T00:00:00Z